# The Containing Coronavirus Disease 19 (COVID-19) Trial

> **NCT04552379** · PHASE3 · COMPLETED · sponsor: **Pontificia Universidad Catolica de Chile** · enrollment: 1173 (actual)

## Conditions studied

- SARS-CoV Infection
- Interferon
- Covid19

## Interventions

- **BIOLOGICAL:** Peginterferon beta-1a

## Key facts

- **NCT ID:** NCT04552379
- **Lead sponsor:** Pontificia Universidad Catolica de Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 1173 (ACTUAL)
- **Last updated:** 2021-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04552379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04552379, "The Containing Coronavirus Disease 19 (COVID-19) Trial". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04552379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*